Search Results - "Kohrt, H.E."

Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy by Makkouk, A., Sundaram, V., Chester, C., Chang, S., Colevas, A.D., Sunwoo, J.B., Maecker, H., Desai, M., Kohrt, H.E.

“…In the era of personalized cancer medicine, identifying techniques for effectively matching patients to efficacious treatments is a critical step in the…”
Get full text

Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens by Khodadoust, Michael S., Olsson, Niclas, Wagar, Lisa E., Haabeth, Ole A. W., Chen, Binbin, Swaminathan, Kavya, Rawson, Keith, Liu, Chih Long, Steiner, David, Lund, Peder, Rao, Samhita, Zhang, Lichao, Marceau, Caleb, Stehr, Henning, Newman, Aaron M., Czerwinski, Debra K., Carlton, Victoria E. H., Moorhead, Martin, Faham, Malek, Kohrt, Holbrook E., Carette, Jan, Green, Michael R., Davis, Mark M., Levy, Ronald, Elias, Joshua E., Alizadeh, Ash A.

“…Evidence for the abundant presentation of class II neoantigens by a human B-cell lymphoma. Uncovering tumour neoantigens Neoantigens created by cancer somatic…”
Get full text

Adoptively Transferred NK Cells Home to Tumor Sites and Accumulate With Tumor Growth But Do Not Lead to Tumor Regression in a Murine B-Cell Lymphoma Model by Gill, S, Florek, M, Kohrt, H.E, Negrin, R.S

Get full text

Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia by Pollyea, D A, Kohrt, H E, Gallegos, L, Figueroa, M E, Abdel-Wahab, O, Zhang, B, Bhattacharya, S, Zehnder, J, Liedtke, M, Gotlib, J R, Coutre, S, Berube, C, Melnick, A, Levine, R, Mitchell, B S, Medeiros, B C

“…Acute myeloid leukemia (AML) is a disease of the elderly. Poor outcomes with standard therapies necessitate novel approaches. Outpatient regimens sufficiently…”
Get full text

Assessment Of The Utility Of Subset Donor Chimerism For Predicting Event-Free Survival After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using TLI And ATG by Logan, A.C, Turnbull, B.B, Lavori, P.W, Miklos, D.B, Negrin, R.S, Lowsky, R, Kohrt, H.E

Get full text

Noninvasive Prediction of Graft-Verus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation by Gene Expression Profiling by Kohrt, H.E, Li, L, Alizadeh, A.A, Heish, S, Goldstein, M.J, Strober, S, Sarwal, M, Lowsky, R

Get full text

Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning by Rezvani, A R, Kanate, A S, Efron, B, Chhabra, S, Kohrt, H E, Shizuru, J A, Laport, G G, Miklos, D B, Benjamin, J E, Johnston, L J, Arai, S, Weng, W-K, Negrin, R S, Strober, S, Lowsky, R

“…We describe 47 patients with lymphoma and failed prior autologous hematopoietic cell transplantation (HCT) who received TLI-ATG (anti-thymocyte globulin)…”
Get full text